Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THEMATIC: FMT in Veterans with Cirrhosis
NCT03796598Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jul 2019
- Primary completion
- Dec 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Fecal Microbiota Transplantation capsules in hepatic encephalopathy (HE) (4 arms), sponsored by VA Office of Research & Development. Primary endpoint: Serious Adverse Events Related to FMT at 6 months. Started Jul 2019; status: completed.
02
Drugs
Fecal Microbiota Transplantation capsules
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT03796598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03796598.